Fact EV/EBIT
Quel est le EV/EBIT de Fact?
Le EV/EBIT de Fact, Inc. est N/A
Quelle est la définition de EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT des entreprises dans Industrials secteur sur OTC par rapport à Fact
Que fait Fact?
Fact, Inc. engages in the art verification and authentication, sports memorabilia, and fine art businesses. It is developing a front-end user interface, as well as modifying existing ballistics firmware for a comprehensive verification, tracking, and reporting system using white light interferometry to take a non-destructive 3D digital fingerprint of the art using approximately 100,000 unique images. The company was formerly known as Tiburon International Trading Corp. and changed its name to Fact, Inc. in November 2020. FACT, Inc. is headquartered in Toronto, Canada. As of October 5, 2020, Fact, Inc. operates as a subsidiary of Kryptos Art Technologies, Inc.
Entreprises avec ev/ebit similaire à Fact
- Frequency Exchange a EV/EBIT de N/A
- Torstar a EV/EBIT de N/A
- Miragen Therapeutics Inc a EV/EBIT de N/A
- Mitesco a EV/EBIT de N/A
- Monumental Minerals Corp a EV/EBIT de N/A
- C4 Therapeutics a EV/EBIT de N/A
- Fact a EV/EBIT de N/A
- BioCardia a EV/EBIT de N/A
- Comprehensive Healthcare Systems a EV/EBIT de N/A
- Progenity a EV/EBIT de N/A
- THC Therapeutics a EV/EBIT de N/A
- RiceBran Technologies a EV/EBIT de N/A
- BioAtla a EV/EBIT de N/A